BioCircuit Technologies, Inc. — Form D
BioCircuit Technologies, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-03. The offering totals $9.0M, of which $9.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-03
- Form: D
- Accession: 0001777259-22-000001
- Industry: Biotechnology
- Exemptions: 04, 06b
- Total offering: $9.0M
- Amount sold: $9.0M
- Investors: 33
- Date of first sale: 2022-09-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-460515
Issuer
- Name: BioCircuit Technologies, Inc.
- CIK: 0001777259
- Entity type: Corporation
- Jurisdiction: GEORGIA
- Incorporated: 2016
- Address: 1819 PEACHTREE ROAD N.E., ATLANTA, GA, 30309
- Phone: 404-433-9035
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michelle Jarrard | Director | Atlanta, GA |
| Michael Masters | Director | Atlanta, GA |
| James Nahirny | Director | Hollis, NH |
| Thomas O'Brien | Director | Jersey City, NJ |
| Michelle Jarrard | Executive Officer | Atlanta, GA |
| Thomas O'Brien | Executive Officer | Jersey City, NJ |
Other filings by this issuer (2)
More